Literature DB >> 3455791

Hematologic malignancy in sickle cell disease: report of four cases and review of the literature.

R B Stricker, C A Linker, T J Crowley, S H Embury.   

Abstract

Hematologic malignancy has rarely been reported in adults with sickle cell disease. We describe four sickle cell patients (two with hemoglobin SC, two with hemoglobin SS) who developed hematologic malignancy (acute myeloblastic leukemia, multiple myeloma, malignant histiocytosis, and Hodgkin's disease). Three of the cases represent the first adult association between SC or SS hemoglobinopathy and the particular malignancy involved. Sickle hemoglobin does not appear to exert a protective effect against childhood hematologic malignancies, suggesting that better survival in sickle cell disease may be accompanied by an increased incidence of hematologic neoplasms in adulthood. Karyotypic analysis revealed alterations of chromosome 5 in two sickle cell patients with leukemia, raising the possibility of a chromosomal link between the two diseases. Further epidemiologic and cytogenetic studies are needed to define the relationship between hematologic malignancy and sickle cell disease.

Entities:  

Mesh:

Year:  1986        PMID: 3455791     DOI: 10.1002/ajh.2830210212

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Chronic lymphocytic leukemia in a patient with sickle cell anemia.

Authors:  H S Kim; L Yospur; Y Niihara
Journal:  West J Med       Date:  1998-08

2.  Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.

Authors:  Olena O Seminog; Oyindamola I Ogunlaja; David Yeates; Michael J Goldacre
Journal:  J R Soc Med       Date:  2016-06-20       Impact factor: 5.344

3.  Increased risk of leukemia among sickle cell disease patients in California.

Authors:  Ann Brunson; Theresa H M Keegan; Heejung Bang; Anjlee Mahajan; Susan Paulukonis; Ted Wun
Journal:  Blood       Date:  2017-08-22       Impact factor: 22.113

4.  Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.

Authors:  Jack Y Ghannam; Xin Xu; Irina Maric; Laura Dillon; Yuesheng Li; Matthew M Hsieh; Christopher S Hourigan; Courtney D Fitzhugh
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

Review 5.  How I use hydroxyurea to treat young patients with sickle cell anemia.

Authors:  Russell E Ware
Journal:  Blood       Date:  2010-03-11       Impact factor: 22.113

6.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

Review 7.  Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature.

Authors:  Maroun Bou Zerdan; Maria Julia Diacovo; Chakra P Chaulagain
Journal:  Am J Case Rep       Date:  2021-12-29

8.  Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.

Authors:  Arianna Barbetta; Cameron Goldbeck; Angelina Lim; Sean P Martin; Jeffrey A Kahn; M Raashid Sheikh; Juliet Emamaullee
Journal:  HPB (Oxford)       Date:  2021-07-06       Impact factor: 3.842

9.  Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.

Authors:  Seda S Tolu; Kai Wang; Zi Yan; Shouping Zhang; Karl Roberts; Andrew S Crouch; Gracy Sebastian; Mark Chaitowitz; Eric D Fornari; Evan M Schwechter; Joan Uehlinger; Deepa Manwani; Caterina P Minniti; Eric E Bouhassira
Journal:  Cells       Date:  2020-09-24       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.